Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study. Prats-Uribe, A., Sena, A. G., Lai, L. Y. H., Ahmed, W. U., Alghoul, H., Alser, O., Alshammari, T. M., Areia, C., Carter, W., Casajust, P., Dawoud, D., Golozar, A., Jonnagaddala, J., Mehta, P. P., Gong, M., Morales, D. R., Nyberg, F., Posada, J. D., Recalde, M., Roel, E., Shah, K., Shah, N. H., Schilling, L. M., Subbian, V., Vizcaya, D., Zhang, L., Zhang, Y., Zhu, H., Liu, L., Cho, J., Lynch, K. E., Matheny, M. E., You, S. C., Rijnbeek, P. R., Hripcsak, G., Lane, J. C., Burn, E., Reich, C., Suchard, M. A., Duarte-Salles, T., Kostka, K., Ryan, P. B., & Prieto-Alhambra, D. BMJ, 373:n1038, 2021.
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study [pdf]Paper  doi  bibtex   

Downloads: 0